U.S. markets open in 7 hours 11 minutes

Cotinga Pharmaceuticals Inc. (COTQF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.05100.0000 (0.00%)
At close: 3:38PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/13/2021
Current
1/31/2020
Market Cap (intraday) 5
1.12M1.33M
Enterprise Value 3
1.46M1.56M
Trailing P/E
N/AN/A
Forward P/E 1
N/AN/A
PEG Ratio (5 yr expected) 1
N/AN/A
Price/Sales (ttm)
N/AN/A
Price/Book (mrq)
7.55N/A
Enterprise Value/Revenue 3
N/AN/A
Enterprise Value/EBITDA 7
-0.69-3.47

Trading Information

Stock Price History

Beta (5Y Monthly) 1.41
52-Week Change 341.67%
S&P500 52-Week Change 348.31%
52 Week High 30.6120
52 Week Low 30.0360
50-Day Moving Average 30.2036
200-Day Moving Average 30.2041

Share Statistics

Avg Vol (3 month) 31.64k
Avg Vol (10 day) 31.87k
Shares Outstanding 521.99M
Implied Shares Outstanding 6N/A
Float 20.51M
% Held by Insiders 18.84%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 29, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jun 29, 2017

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Apr 29, 2019
Most Recent Quarter (mrq)Jan 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-119.87%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-728.24k
EBITDA -2.14M
Net Income Avi to Common (ttm)-2.54M
Diluted EPS (ttm)-0.0920
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)46.11k
Total Cash Per Share (mrq)0
Total Debt (mrq)469.68k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.05
Book Value Per Share (mrq)-0.18

Cash Flow Statement

Operating Cash Flow (ttm)-516.14k
Levered Free Cash Flow (ttm)245.69k